Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna. "Our ...

A study found that around 4 months after vaccination, people who received the RSV vaccine had a 79% reduction in their risk ...

SOME 82 Brits have died after using weight-loss and diabetes jabs such as Ozempic and Mounjaro. The official figures from the ...

The Medicines and Healthcare products Regulatory Agency issued an alert as a crackdown on prescriptions was underway ...

Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.

At least 82 Brits are known to have died after taking weight-loss drugs such as Ozempic and Mounjaro. The Medicines and ...

Medical treatments, including jabs used for weight loss, are monitored in part using the Medicines and Healthcare products ...

This launch follows the nod from the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA), making Biocon the ...

Biocon announced the launch of its GLP-1 peptide, Liraglutide, for diabetes and obesity, in the United Kingdom (U.K.). The drug-device combination will be marketed in the U.K. under the brand names ...

Valneva SE (“Valneva”) announced that the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) ...